Breaking News, Promotions & Moves

Ipsen Appoints EVP, Strategy & Transformation

Laura Réveillon, PhD will serve on the Executive Leadership Team and report directly to Ipsen’s Chief Executive Officer.

Author Image

By: Charlie Sternberg

Associate Editor

Ipsen, a global specialty care-driven biopharmaceutical company, has appointed Laura Réveillon, PhD as EVP, Strategy & Transformation, effective May 14, 2025. She will serve on the Executive Leadership Team and report directly to Ipsen’s Chief Executive Officer (CEO), David Loew. “We are very pleased to welcome Laura to Ipsen as our EVP for Strategy & Transformation. I have observed Laura’s involvement in major transformation projects across leading life science companies in different...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters